About The Publication
Medical Device Developments Vol. 2 2016
A soft robotic gripper invented at the École Polytechnique Fédérale Lausanne (EPFL), Switzerland, is gentle enough to pick up an egg, yet strong enough to carry 80 times its own weight. Sarah Williams speaks to EPFL's Jun Shintake and Herbert Shea about what it could mean for the medical industry, from automated manufacture to prostheses.
Students in Mexico have printed plastic supports for broken limbs that are breathable, able to prevent infection and ulcers, and ten times lighter than plaster casts. Designer Zaid Badwan explains the development of this potentially revolutionary technique.
Also in this issue: Medical Device Developments explains why contract manufacturers in the single market look likely to be placed under increased scrutiny by regulators, and Oliver Hotham reports on a US military hospital that has developed a way to bring the sensation of touch to artificial limbs with new sensors and haptic technology.
Medical Device Developments Vol. 1 2016
When joint replacements repeatedly fail and extensive bone loss occurs, additional revision using a standard orthopaedic prosthesis is often unfeasible and many patients are turned away. Sarah Williams speaks to Michael Colling-Tuck of JRI Orthopaedics to find out how 3D-printed implants are making the inoperable operable and to Nottingham Trent University's Manolis Papastavrou about research into an exciting new approach to 3D printing that could improve treatment options.
With a raft of new regulation on the way from the European Union in the near future, there promises to be a number of testing years ahead for medical device manufacturers. Dr Gabriel Adusei, a medical device consultant at Triune Technologies, outlines how the industry should expect to be affected by the changes and what impact this may have on the med-tech sector.
Also in this issue: Kerry Taylor-Smith speaks to Mr Bobby Qureshi of the London Eye Hospital - the first surgeon in the UK to use femtosecond lasers - about the technology and Medical Device Developments investigates the outsourcing landscape in 2016 with Cirtec CEO Brian Higley and Medi-Vantage president Maria Shepherd.
Medical Device Development Compendium 2016
Medical Device Developments Vol. 2 2015
In 1958, the first pacemaker fully embedded in the human body began its work. No one believed the technique would be a success. But today, in Germany alone, about 130,000 patients each year receive such an implant, giving them a significantly improved quality of life. In the latest edition of Medical Device Developments, CEO of IVAM Thomas Dietrich explores the future of this pioneering technology.
Jack Sandahl, adjunct professor in the manufacturing operations management programme at the University of Minnesota, and fellow, supplier and materials management at Boston Scientific, explores the current contract manufacturing landscape and shares his five-step process for driving performance excellence.
Also in this issue: Sophie Peacock speaks to Dr Blayne Welk, a urologist practicing in Canada, about the increasing medico-legal concerns regarding transvaginal meshes, and Dr Tolou Shokuhfar of Michigan Technological University, and director of In-Situ Nanomedicine Laboratory, explains how advances in nanotechnology might improve the biological performance of bone implants and reduce infection rates.
Medical Device Developments Vol. 1 2015
Miniscule robots that can seek out problem cells and provide targeted treatment inside a patient's body could one day become the norm. As engineers at the University of Texas at Austin trial the world's smallest, fastest and longest-running nanomotor, Dr Donglei (Emma) Fan talks to Medical Device Developments about a new 'bottom-up' approach to nanomechanics.
Following the Protect Medical Innovation Act 2015, the US medical device excise tax may soon be repealed. Two and a half years since it came into force, the tax has already had a significant impact on the industry, presenting opportunities, as well as challenges. We explore how the outsourcing market has been affected and the implications for contract manufacturers partnering with cash-strapped OEMs.
Also in this issue: Matthias Lorenz, deputy chairman of IVAM Focus Group Medical, explains how OEMs decide how to outsource microelectronic products; Dr Dale Athey, CEO of OJ-Bio, explains how medical device designers can take advantage of advanced electronics to test for illnesses remotely; and Procyrion CEO Benjamin Hertzog discusses the need for minimally invasive cardiology tools.
Medical Device Developments Vol. 2 2014
Medical science has come a long way since the first implantable pacemakers were developed in the 1950s. With advances in technology and the emergence of lithium anode cells came increased power management, and in the last few years, we've witnessed some amazing developments.
In this edition of Medical Device Developments, Jack Wittels learns more about the future of leadless pacing and other electrophysiological trends that are changing how patients' heart conditions are treated.
Ellen Roche, a PhD candidate at Harvard University's School of Engineering and Applied Sciences, introduces us to 'soft robotics'. Instead of rigid structures, flexible materials such as silicone elastomers are used to more accurately mimic structures in the body. Roche discusses her work in the field and how it could ultimately lead to devices that help to repair the heart.
Also in this issue: We catch up with the latest in spinal cord injury management - motorised exoskeletons. The technology is relatively simple, but the results are incredible as UK woman Claire Lomas proved when she completed the 2012 London Marathon using the ReWalk. The device allows paralysed patients to walk again and has just received FDA approval for personal use. Mukul Talaty runs us through his research on the safety and efficacy of the product and considers whether or not it represents the future of paralysis treatment.
Medical Device Developments Vol. 1 2014
Smaller is better in this issue, which emphasises developments taking place on a microscopic scale. We talk to Joseph Kahn, professor of electrical engineering at Stanford University, who has developed a prototype micro-endoscope as thin as a human hair. Devices of this kind could enable dozens of new procedures across oncology, brain surgery and even gene therapy.
We also chat to Frederick Balagadde, assistant investigator at K-RITH in South Africa, who makes a compelling case for using microfluidics in the fight against HIV/AIDS. While lab-on-a-chip (LOC) devices have been trumpeted as the future of diagnostics, how can they get off the ground in the developing world?
Another area attracting hype is additive manufacturing, or 3D printing. Professor Kenneth Dalgarno of Newcastle University explains what lies behind the buzz. Elsewhere, Digicom Electronics' Mo Ohady and David Estes walk us through the EMS company selection procedure, Dr Joachim Storsberg of the Fraunhofer Institute explains new uses for biopolymers and Michigan State University's Dr Douglas Moyer talks treating counterfeiters as competitors.
Medical Device Developments Vol. 2 2013
Some manufacturers are realising the benefits that subcontracting to EMS providers can bring, but others are reticent. Frost & Sullivan's Lavanya Rammohan evaluates the medical market's outsourcing potential.
Can the potential of robotics, 3D printing and nanotechnology in the automated manufacture of medical devices truly be realised? We ask Navigant's Scott Thiel. Also in this edition, Chuck Parker, Continua's executive director, explains why he considers M2M communication technology to be critical to the future of healthcare, Tactiq's Alan Johnson outlines what risks must be addressed in the management of power sources for portable medical devices in the critical care environment, and Zeljko Loncaric, marketing engineer at congatec, explains how microprocessor evolution is driving up efficacy within the industry.
Medical Device Developments Vol. 1 2013
Yves Verboven, director market access and economic policies at Eucomed, discusses the multiple pathways that manufacturers need to understand when seeking funding and reimbursement for medical technology for different European countries, and also the solutions.
Elsewhere, Medical Device Developments speaks to consultant Bruce Stanley about how companies can successfully navigate the regulatory landscape and, with increasing numbers of medical device manufacturers embracing automation, Mike Wilson of the British Automation & Robot Association and Todd Olson of NACS discuss its possibilities and drawbacks. Plus, Sachin Shrikant Malgave of Indo-US MIM investigates metal injection moulding and Professor Ian Ward of the University of Leeds talks about some of the leading-edge research in the field of materials innovation.